Literature DB >> 23615044

Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.

Loretta A Williams1, Sonika Agarwal, Diane C Bodurka, Angele K Saleeba, Charlotte C Sun, Charles S Cleeland.   

Abstract

CONTEXT: Experts in patient-reported outcome (PRO) measurement emphasize the importance of including patient input in the development of PRO measures. Although best methods for acquiring this input are not yet identified, patient input early in instrument development ensures that instrument content captures information most important and relevant to patients in understandable terms.
OBJECTIVES: The M. D. Anderson Symptom Inventory (MDASI) is a reliable valid PRO instrument for assessing cancer symptom burden. We report a qualitative (open-ended, in-depth) interviewing method that can be used to incorporate patient input into PRO symptom measure development, with our experience in constructing an MDASI module for ovarian cancer (MDASI-OC) as a model.
METHODS: Fourteen patients with ovarian cancer (OC) described symptoms experienced at the time of the study, at diagnosis, and during prior treatments. Researchers and clinicians used content analysis of interview transcripts to identify symptoms in patient language. Symptoms were ranked on the basis of the number of patients mentioning them and by clinician assessment of relevance.
RESULTS: Forty-two symptoms were mentioned. Eight OC-specific items will be added to the 13 core symptom items and six interference items of the MDASI in a test version of the MDASI-OC on the basis of the number of patients mentioning them and clinician assessment of importance. The test version is undergoing psychometric evaluation.
CONCLUSION: The qualitative interviewing process, used to develop the test MDASI-OC, systematically captures common symptoms important to patients with OC. This methodology incorporates the patient experience recommended by experts in PRO instrument development.
Copyright © 2013 U.S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  M. D. Anderson Symptom Inventory; MDASI; Signs and symptoms; ovarian cancer; patient-reported outcome assessment; qualitative research

Mesh:

Year:  2013        PMID: 23615044      PMCID: PMC3775907          DOI: 10.1016/j.jpainsymman.2013.02.007

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  15 in total

Review 1.  Content validity of self-report measurement instruments: an illustration from the development of the Brain Tumor Module of the M.D. Anderson Symptom Inventory.

Authors:  Terri S Armstrong; Marlene Z Cohen; Lillian Eriksen; Charles Cleeland
Journal:  Oncol Nurs Forum       Date:  2005-05-10       Impact factor: 2.172

2.  Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.

Authors:  Tito R Mendoza; Xin Shelley Wang; Charles Lu; Guadalupe R Palos; Zhongxing Liao; Gary M Mobley; Shitij Kapoor; Charles S Cleeland
Journal:  Oncologist       Date:  2011-02-01

3.  Qualitative research and content validity: developing best practices based on science and experience.

Authors:  Meryl Brod; Laura E Tesler; Torsten L Christensen
Journal:  Qual Life Res       Date:  2009-09-27       Impact factor: 4.147

4.  Sample size in qualitative research.

Authors:  M Sandelowski
Journal:  Res Nurs Health       Date:  1995-04       Impact factor: 2.228

5.  Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.

Authors:  David I Rosenthal; Tito R Mendoza; Mark S Chambers; Joshua A Asper; Ibrahima Gning; Merrill S Kies; Randal S Weber; Jan S Lewin; Adam S Garden; K Kian Ang; Xin S Wang; Charles S Cleeland
Journal:  Head Neck       Date:  2007-10       Impact factor: 3.147

6.  Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory.

Authors:  C S Cleeland; T R Mendoza; X S Wang; C Chou; M T Harle; M Morrissey; M C Engstrom
Journal:  Cancer       Date:  2000-10-01       Impact factor: 6.860

Review 7.  Symptom burden: multiple symptoms and their impact as patient-reported outcomes.

Authors:  Charles S Cleeland
Journal:  J Natl Cancer Inst Monogr       Date:  2007

8.  Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom Inventory.

Authors:  Ibrahima Gning; Peter C Trask; Tito R Mendoza; Margaret T Harle; Karla A Gutierrez; Sheila A Kitaka; Steven I Sherman; Charles S Cleeland
Journal:  Oncology       Date:  2008-12-01       Impact factor: 2.935

9.  Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failure.

Authors:  Anecita Fadol; Tito Mendoza; Ibrahima Gning; Jeanette Kernicki; Lene Symes; Charles S Cleeland; Daniel Lenihan
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

10.  Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.

Authors: 
Journal:  Health Qual Life Outcomes       Date:  2006-10-11       Impact factor: 3.186

View more
  13 in total

1.  What symptoms are important to patients? Developing a symptom burden measure for women with breast cancer.

Authors:  Meagan S Whisenant; Faith A Strunk; Debasish Tripathy; Loretta A Williams
Journal:  Support Care Cancer       Date:  2019-04-02       Impact factor: 3.603

2.  Perioperative trajectory of patient reported symptoms: a pilot study in gynecologic oncology patients.

Authors:  Larissa A Meyer; Alpa M Nick; Qiuling Shi; Xin Shelley Wang; Loretta Williams; Tremaine Brock; Maria D Iniesta; Kelly Rangel; Karen H Lu; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2015-01-31       Impact factor: 5.482

Review 3.  Cancer-related and treatment-related fatigue.

Authors:  Xin Shelley Wang; Jeanie F Woodruff
Journal:  Gynecol Oncol       Date:  2014-10-23       Impact factor: 5.482

4.  Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS).

Authors:  Loretta A Williams; Araceli Garcia-Gonzalez; Tito R Mendoza; Shireen Haq; Charles S Cleeland
Journal:  Support Care Cancer       Date:  2018-08-10       Impact factor: 3.603

5.  Development of a patient-centred, patient-reported outcome measure (PROM) for post-stroke cognitive rehabilitation: qualitative interviews with stroke survivors to inform design and content.

Authors:  Emma L Patchick; Maria Horne; Kate Woodward-Nutt; Andy Vail; Audrey Bowen
Journal:  Health Expect       Date:  2014-12-05       Impact factor: 3.377

6.  Seizures in patients with primary brain tumors: what is their psychosocial impact?

Authors:  John Y Shin; Sani H Kizilbash; Steven I Robinson; Joon H Uhm; Julie E Hammack; Daniel H Lachance; Jan C Buckner; Aminah Jatoi
Journal:  J Neurooncol       Date:  2016-03-15       Impact factor: 4.130

7.  Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale.

Authors:  Tito R Mendoza; Xin Shelley Wang; Loretta A Williams; Qiuling Shi; Elisabeth G Vichaya; Patrick M Dougherty; Sheeba K Thomas; Emre Yucel; Christel C Bastida; Jeanie F Woodruff; Charles S Cleeland
Journal:  J Pain       Date:  2015-07-22       Impact factor: 5.820

8.  Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.

Authors:  Mary H Sailors; Diane C Bodurka; Ibrahima Gning; Lois M Ramondetta; Loretta A Williams; Tito R Mendoza; Sonika Agarwal; Charlotte C Sun; Charles S Cleeland
Journal:  Gynecol Oncol       Date:  2013-05-15       Impact factor: 5.482

9.  Measuring symptoms as a critical component of drug development and evaluation in hematological diseases.

Authors:  Loretta A Williams; Emre Yucel; Jorge E Cortes; Charles S Cleeland
Journal:  Clin Investig (Lond)       Date:  2013-12-01

Review 10.  Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).

Authors:  Loretta A Williams; Meagan S Whisenant; Tito R Mendoza; Shireen Haq; Karen N Keating; Brian Cuffel; Charles S Cleeland
Journal:  Qual Life Res       Date:  2018-09-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.